Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
161M
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
48.6M
-
Shares change
-
-2.35M
-
Total reported value, excl. options
-
$83.6M
-
Value change
-
-$4.32M
-
Put/Call ratio
-
0.65
-
Number of buys
-
36
-
Number of sells
-
-37
-
Price
-
$1.72
Significant Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q3 2023
102 filings reported holding GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share as of Q3 2023.
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.6M shares
of 161M outstanding shares and own 30.28% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (8.51M shares), BlackRock Inc. (6.09M shares), Point72 Asset Management, L.P. (5.92M shares), VANGUARD GROUP INC (4.06M shares), Versant Venture Management, LLC (3.56M shares), Avidity Partners Management LP (2.73M shares), Balyasny Asset Management L.P. (2.04M shares), GEODE CAPITAL MANAGEMENT, LLC (1.77M shares), MORGAN STANLEY (1.76M shares), and STATE STREET CORP (1.6M shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.